BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NYC Learning Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:e891d108-dece-5831-8d6f-98efbef051ba@nyc-learning-events
DTSTAMP:20261029T102808Z
DTSTART:20261104T180000Z
DTEND:20261104T190000Z
STATUS:TENTATIVE
SUMMARY:Antibodies by Design: Accelerating biotherapeutic R&D
LOCATION:Online webinar
URL:https://thinkingnyc.com/events/e891d108-dece-5831-8d6f-98efbef051ba
DESCRIPTION:Conflicting details: Sources disagree about a detail (often the
  time or place). Check the event site before you go.\nScala Biodesign’s 
 co-founders Ravit Netzer and Adi Goldenzweig discuss the science and exper
 imental evidence behind its antibody design technology. They explain how A
 I and physics-based calculations are used to improve multiple antibody pro
 perties and present experimental case studies and the challenges each proj
 ect set out to solve.\n\nDetails: https://thinkingnyc.com/events/e891d108-
 dece-5831-8d6f-98efbef051ba\n\nSource: https://thebiocalendar.com/event/an
 tibodies-by-design-accelerating-biotherapeutic-rd/
END:VEVENT
END:VCALENDAR